Immunoglobulin’s also called as antibodies are large Y-shaped protein produced by B-cell. These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Production of antibodies is an important function of immune system. Antibodies use binding mechanism for neutralizing the activity of a foreign particle called as an antigen.
The global Immunoglobulins market size is projected to reach US$ 13870 million by 2027, from US$ 10910 million in 2020, at a CAGR of 4.1% during 2021-2027.
In terms of production side, this report researches the Immunoglobulins production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Immunoglobulins by regions (countries) and by Application.
The global Immunoglobulins market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Immunoglobulins market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Immunoglobulins markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Immunoglobulins market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Immunoglobulins market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Immunoglobulins market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Immunoglobulins market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Immunoglobulins market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Immunoglobulins market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Immunoglobulins market by each application segment for the same period.
This report includes the following manufacturers:
Hualan Biological Engineering Inc.
Omrix Biopharmaceuticals Ltd.
Behring GmbH
Shanghai RAAS Blood Products
Option Care Enterprises
ADMA Biologics,
BioScrip
Market Segment by Type
IgG
IgA
IgM
IgE
IgD
Market Segment by Application
Hospital
Research
Research Methodology
To compile the detailed study of the global Immunoglobulins market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Immunoglobulins market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Immunoglobulins market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
The global Immunoglobulins market size is projected to reach US$ 13870 million by 2027, from US$ 10910 million in 2020, at a CAGR of 4.1% during 2021-2027.
In terms of production side, this report researches the Immunoglobulins production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Immunoglobulins by regions (countries) and by Application.
The global Immunoglobulins market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Immunoglobulins market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Immunoglobulins markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Immunoglobulins market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Immunoglobulins market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Immunoglobulins market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Immunoglobulins market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Immunoglobulins market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Immunoglobulins market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Immunoglobulins market by each application segment for the same period.
This report includes the following manufacturers:
Hualan Biological Engineering Inc.
Omrix Biopharmaceuticals Ltd.
Behring GmbH
Shanghai RAAS Blood Products
Option Care Enterprises
ADMA Biologics,
BioScrip
Market Segment by Type
IgG
IgA
IgM
IgE
IgD
Market Segment by Application
Hospital
Research
Research Methodology
To compile the detailed study of the global Immunoglobulins market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Immunoglobulins market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Immunoglobulins market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Immunoglobulins Market Size Growth Rate by Type
1.2.2 IgG
1.2.3 IgA
1.2.4 IgM
1.2.5 IgE
1.2.6 IgD
1.3 Market Segment by Application
1.3.1 Global Immunoglobulins Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Hospital
1.3.3 Research
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Immunoglobulins Market Size (2016-2027)
2.1.1 Global Immunoglobulins Revenue (2016-2027)
2.1.2 Global Immunoglobulins Sales (2016-2027)
2.2 Global Immunoglobulins Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Immunoglobulins Sales by Regions (2016-2021)
2.2.2 Global Immunoglobulins Revenue by Regions (2016-2021)
2.3 Global Immunoglobulins Market Size Forecast by Region
2.3.1 Global Immunoglobulins Sales Forecast by Region (2022-2027)
2.3.2 Global Immunoglobulins Revenue Forecast by Region (2022-2027)
2.4 Global Top Immunoglobulins Regions (Countries) Ranking by Market Size
2.5 Immunoglobulins Industry Trends
2.5.1 Immunoglobulins Market Trends
2.5.2 Immunoglobulins Market Drivers
2.5.3 Immunoglobulins Market Challenges
2.5.4 Immunoglobulins Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Immunoglobulins Manufacturers by Sales (2016-2021)
3.1.1 Global Immunoglobulins Sales by Manufacturers (2016-2021)
3.1.2 Global Immunoglobulins Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Immunoglobulins Sales in 2020
3.2 Global Top Manufacturers Immunoglobulins by Revenue
3.2.1 Global Immunoglobulins Revenue by Manufacturers (2016-2021)
3.2.2 Top Immunoglobulins Manufacturers Covered: Ranking by Revenue
3.2.3 Global Immunoglobulins Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Immunoglobulins Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunoglobulins as of 2020)
3.4 Global Immunoglobulins Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Immunoglobulins Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Immunoglobulins Market
3.7 Key Manufacturers Immunoglobulins Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Immunoglobulins Market Size by Type
4.1 Global Immunoglobulins Historic Market Review by Type (2016-2021)
4.1.1 Global Immunoglobulins Sales Market Share by Type (2016-2021)
4.1.2 Global Immunoglobulins Revenue Market Share by Type (2016-2021)
4.1.3 Immunoglobulins Price by Type (2016-2021)
4.2 Global Immunoglobulins Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Immunoglobulins Sales Forecast by Type (2022-2027)
4.2.2 Global Immunoglobulins Revenue Forecast by Type (2022-2027)
4.2.3 Immunoglobulins Price Forecast by Type (2022-2027)
5 Global Immunoglobulins Market Size by Application
5.1 Global Immunoglobulins Historic Market Review by Application (2016-2021)
5.1.1 Global Immunoglobulins Sales Market Share by Application (2016-2021)
5.1.2 Global Immunoglobulins Revenue Market Share by Application (2016-2021)
5.1.3 Immunoglobulins Price by Application (2016-2021)
5.2 Global Immunoglobulins Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Immunoglobulins Sales Forecast by Application (2022-2027)
5.2.2 Global Immunoglobulins Revenue Forecast by Application (2022-2027)
5.2.3 Immunoglobulins Price Forecast by Application (2022-2027)
6 North America
6.1 North America Immunoglobulins Sales Breakdown by Company
6.1.1 North America Immunoglobulins Sales by Company (2016-2027)
6.1.2 North America Immunoglobulins Revenue by Company (2016-2027)
6.2 North America Immunoglobulins Market Size by Type (2016-2027)
6.2.1 North America Immunoglobulins Sales by Type (2016-2027)
6.2.2 North America Immunoglobulins Revenue by Type (2016-2027)
6.3 North America Immunoglobulins Market Size by Application (2016-2027)
6.3.1 North America Immunoglobulins Sales by Application (2016-2027)
6.3.2 North America Immunoglobulins Revenue by Application (2016-2027)
6.4 North America Immunoglobulins Market Size by Country
6.4.1 North America Immunoglobulins Sales by Country (2016-2027)
6.4.2 North America Immunoglobulins Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Immunoglobulins Sales Breakdown by Company
7.1.1 Europe Immunoglobulins Sales by Company (2016-2027)
7.1.2 Europe Immunoglobulins Revenue by Company (2016-2027)
7.2 Europe Immunoglobulins Market Size by Type (2016-2027)
7.2.1 Europe Immunoglobulins Sales by Type (2016-2027)
7.2.2 Europe Immunoglobulins Revenue by Type (2016-2027)
7.3 Europe Immunoglobulins Market Size by Application (2016-2027)
7.3.1 Europe Immunoglobulins Sales by Application (2016-2027)
7.3.2 Europe Immunoglobulins Revenue by Application (2016-2027)
7.4 Europe Immunoglobulins Market Size by Country
7.4.1 Europe Immunoglobulins Sales by Country (2016-2027)
7.4.2 Europe Immunoglobulins Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Immunoglobulins Sales Breakdown by Company
8.1.1 Asia Pacific Immunoglobulins Sales by Company (2016-2027)
8.1.2 Asia Pacific Immunoglobulins Revenue by Company (2016-2027)
8.2 Asia Pacific Immunoglobulins Market Size by Type (2016-2027)
8.2.1 Asia Pacific Immunoglobulins Sales by Type (2016-2027)
8.2.2 Asia Pacific Immunoglobulins Revenue by Type (2016-2027)
8.3 Asia Pacific Immunoglobulins Market Size by Application (2016-2027)
8.3.1 Asia Pacific Immunoglobulins Sales by Application (2016-2027)
8.3.2 Asia Pacific Immunoglobulins Revenue by Application (2016-2027)
8.4 Asia Pacific Immunoglobulins Market Size by Regions
8.4.1 Asia Pacific Immunoglobulins Sales by Regions
8.4.2 Asia Pacific Immunoglobulins Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Immunoglobulins Sales Breakdown by Company
9.1.1 Latin America Immunoglobulins Sales by Company (2016-2027)
9.1.2 Latin America Immunoglobulins Revenue by Company (2016-2027)
9.2 Latin America Immunoglobulins Market Size by Type (2016-2027)
9.2.1 Latin America Immunoglobulins Sales by Type (2016-2027)
9.2.2 Latin America Immunoglobulins Revenue by Type (2016-2027)
9.3 Latin America Immunoglobulins Market Size by Application (2016-2027)
9.3.1 Latin America Immunoglobulins Sales by Application (2016-2027)
9.3.2 Latin America Immunoglobulins Revenue by Application (2016-2027)
9.4 Latin America Immunoglobulins Market Size by Country
9.4.1 Latin America Immunoglobulins Sales by Country (2016-2027)
9.4.2 Latin America Immunoglobulins Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Immunoglobulins Sales Breakdown by Company
10.1.1 Middle East and Africa Immunoglobulins Sales by Company (2016-2027)
10.1.2 Middle East and Africa Immunoglobulins Revenue by Company (2016-2027)
10.2 Middle East and Africa Immunoglobulins Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Immunoglobulins Sales by Type (2016-2027)
10.2.2 Middle East and Africa Immunoglobulins Revenue by Type (2016-2027)
10.3 Middle East and Africa Immunoglobulins Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Immunoglobulins Sales by Application (2016-2027)
10.3.2 Middle East and Africa Immunoglobulins Revenue by Application (2016-2027)
10.4 Middle East and Africa Immunoglobulins Market Size by Country
10.4.1 Middle East and Africa Immunoglobulins Sales by Country (2016-2027)
10.4.2 Middle East and Africa Immunoglobulins Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Hualan Biological Engineering Inc.
11.1.1 Hualan Biological Engineering Inc. Corporation Information
11.1.2 Hualan Biological Engineering Inc. Overview
11.1.3 Hualan Biological Engineering Inc. Immunoglobulins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Hualan Biological Engineering Inc. Immunoglobulins Products and Services
11.1.5 Hualan Biological Engineering Inc. Immunoglobulins SWOT Analysis
11.1.6 Hualan Biological Engineering Inc. Recent Developments
11.2 Omrix Biopharmaceuticals Ltd.
11.2.1 Omrix Biopharmaceuticals Ltd. Corporation Information
11.2.2 Omrix Biopharmaceuticals Ltd. Overview
11.2.3 Omrix Biopharmaceuticals Ltd. Immunoglobulins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Omrix Biopharmaceuticals Ltd. Immunoglobulins Products and Services
11.2.5 Omrix Biopharmaceuticals Ltd. Immunoglobulins SWOT Analysis
11.2.6 Omrix Biopharmaceuticals Ltd. Recent Developments
11.3 Behring GmbH
11.3.1 Behring GmbH Corporation Information
11.3.2 Behring GmbH Overview
11.3.3 Behring GmbH Immunoglobulins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Behring GmbH Immunoglobulins Products and Services
11.3.5 Behring GmbH Immunoglobulins SWOT Analysis
11.3.6 Behring GmbH Recent Developments
11.4 Shanghai RAAS Blood Products
11.4.1 Shanghai RAAS Blood Products Corporation Information
11.4.2 Shanghai RAAS Blood Products Overview
11.4.3 Shanghai RAAS Blood Products Immunoglobulins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Shanghai RAAS Blood Products Immunoglobulins Products and Services
11.4.5 Shanghai RAAS Blood Products Immunoglobulins SWOT Analysis
11.4.6 Shanghai RAAS Blood Products Recent Developments
11.5 Option Care Enterprises
11.5.1 Option Care Enterprises Corporation Information
11.5.2 Option Care Enterprises Overview
11.5.3 Option Care Enterprises Immunoglobulins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Option Care Enterprises Immunoglobulins Products and Services
11.5.5 Option Care Enterprises Immunoglobulins SWOT Analysis
11.5.6 Option Care Enterprises Recent Developments
11.6 ADMA Biologics,
11.6.1 ADMA Biologics, Corporation Information
11.6.2 ADMA Biologics, Overview
11.6.3 ADMA Biologics, Immunoglobulins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 ADMA Biologics, Immunoglobulins Products and Services
11.6.5 ADMA Biologics, Immunoglobulins SWOT Analysis
11.6.6 ADMA Biologics, Recent Developments
11.7 BioScrip
11.7.1 BioScrip Corporation Information
11.7.2 BioScrip Overview
11.7.3 BioScrip Immunoglobulins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 BioScrip Immunoglobulins Products and Services
11.7.5 BioScrip Immunoglobulins SWOT Analysis
11.7.6 BioScrip Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Immunoglobulins Value Chain Analysis
12.2 Immunoglobulins Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Immunoglobulins Production Mode & Process
12.4 Immunoglobulins Sales and Marketing
12.4.1 Immunoglobulins Sales Channels
12.4.2 Immunoglobulins Distributors
12.5 Immunoglobulins Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Immunoglobulins Market Size Growth Rate by Type
1.2.2 IgG
1.2.3 IgA
1.2.4 IgM
1.2.5 IgE
1.2.6 IgD
1.3 Market Segment by Application
1.3.1 Global Immunoglobulins Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Hospital
1.3.3 Research
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Immunoglobulins Market Size (2016-2027)
2.1.1 Global Immunoglobulins Revenue (2016-2027)
2.1.2 Global Immunoglobulins Sales (2016-2027)
2.2 Global Immunoglobulins Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Immunoglobulins Sales by Regions (2016-2021)
2.2.2 Global Immunoglobulins Revenue by Regions (2016-2021)
2.3 Global Immunoglobulins Market Size Forecast by Region
2.3.1 Global Immunoglobulins Sales Forecast by Region (2022-2027)
2.3.2 Global Immunoglobulins Revenue Forecast by Region (2022-2027)
2.4 Global Top Immunoglobulins Regions (Countries) Ranking by Market Size
2.5 Immunoglobulins Industry Trends
2.5.1 Immunoglobulins Market Trends
2.5.2 Immunoglobulins Market Drivers
2.5.3 Immunoglobulins Market Challenges
2.5.4 Immunoglobulins Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Immunoglobulins Manufacturers by Sales (2016-2021)
3.1.1 Global Immunoglobulins Sales by Manufacturers (2016-2021)
3.1.2 Global Immunoglobulins Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Immunoglobulins Sales in 2020
3.2 Global Top Manufacturers Immunoglobulins by Revenue
3.2.1 Global Immunoglobulins Revenue by Manufacturers (2016-2021)
3.2.2 Top Immunoglobulins Manufacturers Covered: Ranking by Revenue
3.2.3 Global Immunoglobulins Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Immunoglobulins Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunoglobulins as of 2020)
3.4 Global Immunoglobulins Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Immunoglobulins Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Immunoglobulins Market
3.7 Key Manufacturers Immunoglobulins Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Immunoglobulins Market Size by Type
4.1 Global Immunoglobulins Historic Market Review by Type (2016-2021)
4.1.1 Global Immunoglobulins Sales Market Share by Type (2016-2021)
4.1.2 Global Immunoglobulins Revenue Market Share by Type (2016-2021)
4.1.3 Immunoglobulins Price by Type (2016-2021)
4.2 Global Immunoglobulins Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Immunoglobulins Sales Forecast by Type (2022-2027)
4.2.2 Global Immunoglobulins Revenue Forecast by Type (2022-2027)
4.2.3 Immunoglobulins Price Forecast by Type (2022-2027)
5 Global Immunoglobulins Market Size by Application
5.1 Global Immunoglobulins Historic Market Review by Application (2016-2021)
5.1.1 Global Immunoglobulins Sales Market Share by Application (2016-2021)
5.1.2 Global Immunoglobulins Revenue Market Share by Application (2016-2021)
5.1.3 Immunoglobulins Price by Application (2016-2021)
5.2 Global Immunoglobulins Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Immunoglobulins Sales Forecast by Application (2022-2027)
5.2.2 Global Immunoglobulins Revenue Forecast by Application (2022-2027)
5.2.3 Immunoglobulins Price Forecast by Application (2022-2027)
6 North America
6.1 North America Immunoglobulins Sales Breakdown by Company
6.1.1 North America Immunoglobulins Sales by Company (2016-2027)
6.1.2 North America Immunoglobulins Revenue by Company (2016-2027)
6.2 North America Immunoglobulins Market Size by Type (2016-2027)
6.2.1 North America Immunoglobulins Sales by Type (2016-2027)
6.2.2 North America Immunoglobulins Revenue by Type (2016-2027)
6.3 North America Immunoglobulins Market Size by Application (2016-2027)
6.3.1 North America Immunoglobulins Sales by Application (2016-2027)
6.3.2 North America Immunoglobulins Revenue by Application (2016-2027)
6.4 North America Immunoglobulins Market Size by Country
6.4.1 North America Immunoglobulins Sales by Country (2016-2027)
6.4.2 North America Immunoglobulins Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Immunoglobulins Sales Breakdown by Company
7.1.1 Europe Immunoglobulins Sales by Company (2016-2027)
7.1.2 Europe Immunoglobulins Revenue by Company (2016-2027)
7.2 Europe Immunoglobulins Market Size by Type (2016-2027)
7.2.1 Europe Immunoglobulins Sales by Type (2016-2027)
7.2.2 Europe Immunoglobulins Revenue by Type (2016-2027)
7.3 Europe Immunoglobulins Market Size by Application (2016-2027)
7.3.1 Europe Immunoglobulins Sales by Application (2016-2027)
7.3.2 Europe Immunoglobulins Revenue by Application (2016-2027)
7.4 Europe Immunoglobulins Market Size by Country
7.4.1 Europe Immunoglobulins Sales by Country (2016-2027)
7.4.2 Europe Immunoglobulins Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Immunoglobulins Sales Breakdown by Company
8.1.1 Asia Pacific Immunoglobulins Sales by Company (2016-2027)
8.1.2 Asia Pacific Immunoglobulins Revenue by Company (2016-2027)
8.2 Asia Pacific Immunoglobulins Market Size by Type (2016-2027)
8.2.1 Asia Pacific Immunoglobulins Sales by Type (2016-2027)
8.2.2 Asia Pacific Immunoglobulins Revenue by Type (2016-2027)
8.3 Asia Pacific Immunoglobulins Market Size by Application (2016-2027)
8.3.1 Asia Pacific Immunoglobulins Sales by Application (2016-2027)
8.3.2 Asia Pacific Immunoglobulins Revenue by Application (2016-2027)
8.4 Asia Pacific Immunoglobulins Market Size by Regions
8.4.1 Asia Pacific Immunoglobulins Sales by Regions
8.4.2 Asia Pacific Immunoglobulins Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Immunoglobulins Sales Breakdown by Company
9.1.1 Latin America Immunoglobulins Sales by Company (2016-2027)
9.1.2 Latin America Immunoglobulins Revenue by Company (2016-2027)
9.2 Latin America Immunoglobulins Market Size by Type (2016-2027)
9.2.1 Latin America Immunoglobulins Sales by Type (2016-2027)
9.2.2 Latin America Immunoglobulins Revenue by Type (2016-2027)
9.3 Latin America Immunoglobulins Market Size by Application (2016-2027)
9.3.1 Latin America Immunoglobulins Sales by Application (2016-2027)
9.3.2 Latin America Immunoglobulins Revenue by Application (2016-2027)
9.4 Latin America Immunoglobulins Market Size by Country
9.4.1 Latin America Immunoglobulins Sales by Country (2016-2027)
9.4.2 Latin America Immunoglobulins Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Immunoglobulins Sales Breakdown by Company
10.1.1 Middle East and Africa Immunoglobulins Sales by Company (2016-2027)
10.1.2 Middle East and Africa Immunoglobulins Revenue by Company (2016-2027)
10.2 Middle East and Africa Immunoglobulins Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Immunoglobulins Sales by Type (2016-2027)
10.2.2 Middle East and Africa Immunoglobulins Revenue by Type (2016-2027)
10.3 Middle East and Africa Immunoglobulins Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Immunoglobulins Sales by Application (2016-2027)
10.3.2 Middle East and Africa Immunoglobulins Revenue by Application (2016-2027)
10.4 Middle East and Africa Immunoglobulins Market Size by Country
10.4.1 Middle East and Africa Immunoglobulins Sales by Country (2016-2027)
10.4.2 Middle East and Africa Immunoglobulins Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Hualan Biological Engineering Inc.
11.1.1 Hualan Biological Engineering Inc. Corporation Information
11.1.2 Hualan Biological Engineering Inc. Overview
11.1.3 Hualan Biological Engineering Inc. Immunoglobulins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Hualan Biological Engineering Inc. Immunoglobulins Products and Services
11.1.5 Hualan Biological Engineering Inc. Immunoglobulins SWOT Analysis
11.1.6 Hualan Biological Engineering Inc. Recent Developments
11.2 Omrix Biopharmaceuticals Ltd.
11.2.1 Omrix Biopharmaceuticals Ltd. Corporation Information
11.2.2 Omrix Biopharmaceuticals Ltd. Overview
11.2.3 Omrix Biopharmaceuticals Ltd. Immunoglobulins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Omrix Biopharmaceuticals Ltd. Immunoglobulins Products and Services
11.2.5 Omrix Biopharmaceuticals Ltd. Immunoglobulins SWOT Analysis
11.2.6 Omrix Biopharmaceuticals Ltd. Recent Developments
11.3 Behring GmbH
11.3.1 Behring GmbH Corporation Information
11.3.2 Behring GmbH Overview
11.3.3 Behring GmbH Immunoglobulins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Behring GmbH Immunoglobulins Products and Services
11.3.5 Behring GmbH Immunoglobulins SWOT Analysis
11.3.6 Behring GmbH Recent Developments
11.4 Shanghai RAAS Blood Products
11.4.1 Shanghai RAAS Blood Products Corporation Information
11.4.2 Shanghai RAAS Blood Products Overview
11.4.3 Shanghai RAAS Blood Products Immunoglobulins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Shanghai RAAS Blood Products Immunoglobulins Products and Services
11.4.5 Shanghai RAAS Blood Products Immunoglobulins SWOT Analysis
11.4.6 Shanghai RAAS Blood Products Recent Developments
11.5 Option Care Enterprises
11.5.1 Option Care Enterprises Corporation Information
11.5.2 Option Care Enterprises Overview
11.5.3 Option Care Enterprises Immunoglobulins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Option Care Enterprises Immunoglobulins Products and Services
11.5.5 Option Care Enterprises Immunoglobulins SWOT Analysis
11.5.6 Option Care Enterprises Recent Developments
11.6 ADMA Biologics,
11.6.1 ADMA Biologics, Corporation Information
11.6.2 ADMA Biologics, Overview
11.6.3 ADMA Biologics, Immunoglobulins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 ADMA Biologics, Immunoglobulins Products and Services
11.6.5 ADMA Biologics, Immunoglobulins SWOT Analysis
11.6.6 ADMA Biologics, Recent Developments
11.7 BioScrip
11.7.1 BioScrip Corporation Information
11.7.2 BioScrip Overview
11.7.3 BioScrip Immunoglobulins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 BioScrip Immunoglobulins Products and Services
11.7.5 BioScrip Immunoglobulins SWOT Analysis
11.7.6 BioScrip Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Immunoglobulins Value Chain Analysis
12.2 Immunoglobulins Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Immunoglobulins Production Mode & Process
12.4 Immunoglobulins Sales and Marketing
12.4.1 Immunoglobulins Sales Channels
12.4.2 Immunoglobulins Distributors
12.5 Immunoglobulins Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
